Skip to main content

Table 4 Multivariate logistic regression for 178 dogs with available long term outcome (PMM (n = 45) and control dogs (n = 133)) examining risk factors’ influence on recovery of the ability to walk at 6 months

From: Risk factors associated with progressive myelomalacia in dogs with complete sensorimotor loss following intervertebral disc extrusion: a retrospective case-control study

 WalkingNot walkingP-valueORCI
Breed
 • Dachshund49450.851.070.52–2.19
 • Cocker Spaniel3140.232.50.57–11.1
 • Other643Ref  
Sex
 • Female intact970.701.260.37–4.33
 • Female spayed34450.200.610.29–1.29
 • Male intact13130.620.770.28–2.12
 • Male neutered3027Ref  
Age
 • ≤ 6 y66750.81.10.48–2.54
 • > 6 y2017Ref  
Site
 • Intumescence11210.082.190.90–5.37
 • Thoracolumbar7571Ref  
Extent of extrusion
 • Extensive26480.0062.61.3–5.3
 • Focal6044Ref  
Time from onset of clinical signs to loss of ambulation  0.48  
 • ≤6 h2736Ref1.40.54–3.53
 • 6-12 h16180.50.920.34–2.47
 • 12-24 h13180.871.90.62–5.92
 • 24-48 h1190.262.00.76–5.64
 • > 48 h19110.166 
Time from loss of ambulation to surgery  0.8  
 • ≤12 h2020Ref0.780.3–1.8
 • 12-24 h34410.580.740.3–1.9
 • > 24 h32310.53  
Treatment with NSAIDs
 • No58620.681.20.57–2.45
 • Yes2830Ref  
Treatment with steroid
 • No48630.11.80.8–3.8
 • Yes3829Ref  
  1. PMM progressive myelomalacia, OR odds ratio, CI confidence interval, Ref reference, NSAID non-steroidal anti-inflammatory drug